China study: PSA screening is effective for early detection of prostate cancer
Sunday, January 31st, 2010 Posted in prostate cancer diagnosis | No Comments »As previous studies have suggested that implementation of PSA screening in China is of crucial importance, a recent study at Nanjing Medical University, China, compared clinical and pathological characteristics of screen-detected and clinically diagnosed prostate cancers and evaluated the effectiveness ...
New scan may help find aggressive prostate tumors
Friday, January 29th, 2010 Posted in prostate cancer diagnosis | No Comments »According to recent report of Leo L. Cheng, an assistant professor of radiology and pathology at Harvard Medical School and a researcher at Massachusetts General Hospital, a new imaging technology promises to achieve the long-sought goal of singling out prostate ...
Bone mineral content and prostate cancer risk
Thursday, January 28th, 2010 Posted in prostate cancer risks | No Comments »A recent study aimed to determine whether there might be differences in bone mineral content between men who develop life-threatening prostate cancer and those who do not, as bone is a common site of prostate cancer metastases. According to study findings, ...
Biochemical profile may help diagnose, determine aggressiveness of prostate cancer
Wednesday, January 27th, 2010 Posted in prostate cancer, prostate cancer diagnosis | No Comments »Magnetic resonance (MR) spectroscopy – which analyzes the biochemistry rather than the structure of tissues – may someday be able both to pinpoint the precise location of prostate cancer and to determine the tumor's aggressiveness, information that could help guide ...
Diabetes and outcomes after radical prostatectomy
Tuesday, January 26th, 2010 Posted in prostate cancer risks | No Comments »Diabetes is associated with lower prostate cancer risk. The association of diabetes with prostate cancer outcomes is less clear. A new stydy at Duke University School of Medicine, Durham, USA, examined the association between diabetes and outcomes after radical prostatectomy ...
Study confirms prostate cancer is treated differently at county vs. private hospitals
Monday, January 25th, 2010 Posted in prostate cancer | No Comments »A recent study related to prostate cancer treatments provided to men with relatively advanced forms of disease suggests that where patients were treated had at least as much (and probably more) impact on their treatment as their actual clinical condition. According ...
Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy
Sunday, January 24th, 2010 Posted in hormone therapy, radiation therapy | No Comments »Discrepancies exist regarding the impact of neoadjuvant hormone therapy (NHT) on the risk of all-cause mortality (ACM) in men who receive brachytherapy for localized prostate cancer. Therefore, the latest study at Harvard Radiation Oncology Program, Boston, Massachusetts targeted to examine ...
HIFU success depends by surgeon’s experience
Friday, January 22nd, 2010 Posted in hifu | No Comments »A recent study at Department of Urology and Andrology, CHU Reims, Reims, France, aimed to report on technical incidents and early and late complications occurring in high-intensity focused ultrasound (HIFU) treatment of patients with localized prostate cancer. The study team ...
Low dose, alternating electric current inhibits growth of prostate cancer
Thursday, January 21st, 2010 Posted in prostate cancer | No Comments »A group of researchers at the University of Washington working with LaZure Scientific have tested a new low-dose alternating electric current (LDAEC) device for the treatment of prostate tumors. All the work was performed in xenograft models. In the online edition ...
Pathology of prostate cancer and focal therapy
Wednesday, January 20th, 2010 Posted in prostate cancer | No Comments »By definition, focal therapy of the prostate is prostate gland ablation aiming at eradication of unifocal low-risk prostate cancer, and preserving uninvolved (peri-) prostatic tissue and therefore quality of life. The technology needed to ablate small regions or sectors of the ...